Elizabeth A. Burkhart

Array ( [id] => 6817424 [patent_doc_number] => 20030068382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer' [patent_app_type] => new [patent_app_number] => 10/226288 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23608 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068382.pdf [firstpage_image] =>[orig_patent_app_number] => 10226288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958626 [patent_doc_number] => 06953570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy' [patent_app_type] => utility [patent_app_number] => 10/225303 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 12978 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953570.pdf [firstpage_image] =>[orig_patent_app_number] => 10225303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735095 [patent_doc_number] => 20030012730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Preparation of radiolabelled haloaromatics via polymer-bound intermediates' [patent_app_type] => new [patent_app_number] => 10/224261 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5907 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012730.pdf [firstpage_image] =>[orig_patent_app_number] => 10224261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 481553 [patent_doc_number] => 07220401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Blood clot-targeted nanoparticles' [patent_app_type] => utility [patent_app_number] => 10/225024 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5310 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220401.pdf [firstpage_image] =>[orig_patent_app_number] => 10225024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379302 [patent_doc_number] => 20040028737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same' [patent_app_type] => new [patent_app_number] => 10/216315 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4572 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028737.pdf [firstpage_image] =>[orig_patent_app_number] => 10216315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073411 [patent_doc_number] => 06838074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent' [patent_app_type] => utility [patent_app_number] => 10/214429 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62271 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838074.pdf [firstpage_image] =>[orig_patent_app_number] => 10214429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979173 [patent_doc_number] => 06930177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'High-purity lanthanum isoproxide and a process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/214338 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5262 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930177.pdf [firstpage_image] =>[orig_patent_app_number] => 10214338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1083141 [patent_doc_number] => 06833442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-21 [patent_title] => 'Complex and method for producing epoxides by using the complex' [patent_app_type] => B2 [patent_app_number] => 10/211548 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5679 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833442.pdf [firstpage_image] =>[orig_patent_app_number] => 10211548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1361607 [patent_doc_number] => 06565829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => '5-arylsulfonyl indoles useful for treating disease' [patent_app_type] => B2 [patent_app_number] => 10/210377 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20930 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/565/06565829.pdf [firstpage_image] =>[orig_patent_app_number] => 10210377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 356033 [patent_doc_number] => 07488466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Preparation for determining pyrimidine metabolic capacity' [patent_app_type] => utility [patent_app_number] => 10/208851 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11002 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488466.pdf [firstpage_image] =>[orig_patent_app_number] => 10208851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395393 [patent_doc_number] => 20040022733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Conjugated lysine copolymers' [patent_app_type] => new [patent_app_number] => 10/209993 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5269 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022733.pdf [firstpage_image] =>[orig_patent_app_number] => 10209993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395378 [patent_doc_number] => 20040022729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Method for binding molecular agents to angiogencic blood vessels' [patent_app_type] => new [patent_app_number] => 10/209733 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7427 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022729.pdf [firstpage_image] =>[orig_patent_app_number] => 10209733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116195 [patent_doc_number] => 20050069496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Methods of screening, determining, developing and utilizing negative cross resistance toxins' [patent_app_type] => utility [patent_app_number] => 10/485477 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24819 [patent_no_of_claims] => 166 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069496.pdf [firstpage_image] =>[orig_patent_app_number] => 10485477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829164 [patent_doc_number] => 20030180222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Peptide-based multimeric targeted contrast agents' [patent_app_type] => new [patent_app_number] => 10/209183 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27343 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180222.pdf [firstpage_image] =>[orig_patent_app_number] => 10209183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782480 [patent_doc_number] => 06991775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Peptide-based multimeric targeted contrast agents' [patent_app_type] => utility [patent_app_number] => 10/209172 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 4 [patent_no_of_words] => 26910 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/991/06991775.pdf [firstpage_image] =>[orig_patent_app_number] => 10209172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402137 [patent_doc_number] => 20020182153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Method for detecting chitin-containing organisms' [patent_app_type] => new [patent_app_number] => 10/200984 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2613 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182153.pdf [firstpage_image] =>[orig_patent_app_number] => 10200984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658266 [patent_doc_number] => 20030133903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Compositions for treatment of prostate cancers and methods of making and using the same' [patent_app_type] => new [patent_app_number] => 10/200040 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37030 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133903.pdf [firstpage_image] =>[orig_patent_app_number] => 10200040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869417 [patent_doc_number] => 20030082106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage' [patent_app_type] => new [patent_app_number] => 10/200477 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6076 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082106.pdf [firstpage_image] =>[orig_patent_app_number] => 10200477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 506837 [patent_doc_number] => 07198775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Detectably labeled porphyrin compound for identifying the sentinel lymph node' [patent_app_type] => utility [patent_app_number] => 10/199660 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3632 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/198/07198775.pdf [firstpage_image] =>[orig_patent_app_number] => 10199660 [rel_patent_id] =>[rel_patent_doc_number] =>)